Welcome to our dedicated page for Cigna Group news (Ticker: CI), a resource for investors and traders seeking the latest updates and insights on Cigna Group stock.
The Cigna Group (NYSE: CI) is a global health company whose news flow reflects its broad role across health insurance, pharmacy benefit services, specialty pharmacy, care services, and health research. Company announcements frequently emphasize its focus on health, vitality, and community, and they highlight activities under both the Cigna Healthcare and Evernorth Health Services brands.
Investors and observers following The Cigna Group’s news can expect regular earnings releases and outlook updates, including quarterly financial results, segment performance for Evernorth Health Services and Cigna Healthcare, and commentary on adjusted income from operations. These releases often discuss drivers such as pharmacy benefit services growth, specialty pharmacy volume, medical care ratios, and the impact of portfolio changes like the divestiture of certain Medicare businesses.
News from The Cigna Group also covers capital and governance developments, such as dividend declarations, debt offerings and use of proceeds, and changes to Board committee structures and membership. SEC-related communications and press releases may describe new senior notes, committee realignments, and Board retirements or appointments.
Another recurring theme in the company’s news is health services and innovation. Through Evernorth Health Services, The Cigna Group has announced initiatives such as a rebate-free pharmacy benefit model designed to make negotiated discounts available upfront and to support local pharmacies, as well as workplace-based care collaborations like the Hankook Tire Clinic Powered by Evernorth. These stories illustrate how the company applies its pharmacy, care, and benefit capabilities in real-world settings.
The Cigna Group also issues research and community-focused news, including its Vitality in America reports on purpose and health, and sponsorships like the Achilles Freedom Team for wounded veterans and adaptive athletes. For anyone tracking CI, the news stream offers insight into financial performance, strategic direction, health services innovation, and community engagement. Bookmarking this page provides a centralized view of these ongoing developments.
Cigna Corporation (NYSE: CI) has completed a $5.4 billion divestiture of its life, accident, and supplemental benefits businesses across six Asia-Pacific markets to Chubb (NYSE: CB). This strategic shift allows Cigna to refocus on its global health portfolio, while expecting approximately $5.1 billion in net after-tax proceeds. The funds will primarily support a share repurchase program, reinforcing Cigna's commitment to enhancing shareholder value. This transaction does not affect Cigna's health operations in North America and other regions.
Summary not available.
AM Best has upgraded the outlook for Cigna Corporation's Long-Term Issuer Credit Rating (Long-Term ICR) from stable to positive while affirming its Financial Strength Rating (FSR) of A (Excellent). The Long-Term ICRs for Cigna's key U.S. and European subsidiaries were also revised to positive. Cigna's strong balance sheet, improved risk-adjusted capitalization, and stable earnings are highlighted. However, the company faces elevated financial leverage of about 42% and significant goodwill from the Express Scripts acquisition. Overall, positive growth is projected for core businesses in 2022.
Cigna Corporation (NYSE: CI) has announced a significant $3.5 billion accelerated stock repurchase program as part of its ongoing commitment to enhance shareholder value. This initiative is part of Cigna's broader share repurchase strategy, which retains an authority of approximately $8.8 billion as of June 14, 2022. Cigna aims to repurchase at least $7 billion of shares in 2022, signaling confidence in its cash flow and business strength. The initial share delivery is expected on July 6, 2022, with final settlement anticipated in the fourth quarter of 2022.
Cigna Corporation (NYSE: CI) announced that CFO Brian Evanko will present at the Goldman Sachs 43rd Annual Global Healthcare Conference on June 14, 2022, in Rancho Palos Verdes, CA. The presentation is scheduled to start at approximately 2:20 p.m. ET. A live webcast will be available on Cigna's Investor Relations website, allowing stakeholders to access the discussion and updates regarding the company's performance and strategies. Cigna focuses on improving health and well-being through integrated health services, maintaining a global presence with over 190 million customer relationships.
Cigna Corporation (NYSE: CI) reported robust first quarter 2022 results with total revenues of $44.0 billion and adjusted revenues of $44.1 billion, reflecting growth across its businesses. Shareholders earned $1.2 billion or $3.68 per share, up from $3.30 last year. Adjusted income from operations rose to $1.9 billion, or $6.01 per share. The total customer base grew by 3% year-to-date to 190.4 million, while Cigna's 2022 outlook projects at least $177 billion in adjusted revenues. The company continues to invest in innovation and partnerships.
Cigna Corporation (NYSE: CI) has launched a new provider consult service to enhance health outcomes for patients with complex cancers. This service leverages Cigna's Evernorth health services to connect patients and community oncologists with experts from National Cancer Institute designated centers. In pilot results, 40% of patients received beneficial treatment recommendations based on updated research. The initiative aims to improve patient care, showcasing Cigna's integrated oncology solutions that support patients throughout their cancer journey.
Cigna Corporation (NYSE: CI) declared a cash dividend of $1.12 per share of common stock, scheduled for payment on June 23, 2022. Shareholders of record will be confirmed as of the close of business on June 8, 2022. This move reflects Cigna's commitment to returning value to its shareholders, maintaining strong financial health and operational stability.
Summary not available.
Cigna Corporation (NYSE:CI) announced that CFO Brian Evanko will present at the BofA Securities 2022 Healthcare Conference on May 11, 2022, at approximately 1:40 p.m. ET in Las Vegas. A live webcast of the presentation will be available on Cigna's investor relations website. Cigna, a global health services company, aims to enhance health and well-being through comprehensive healthcare solutions and maintains a strong international presence with over 185 million customer relationships across more than 30 countries.